NEKTAR THERAPEUTICS (NKTR) Form 8-K Material Events
NEKTAR THERAPEUTICS (NKTR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NKTR
CIK: 906709
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAbdul Kazi
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-01 | 2026-10-01 | CURRENT REPORT | 0001213900-26-105453 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-28 | — | SCHEDULE 13G/A Filing | 0001193125-26-403411 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-403105 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-403103 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-403101 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-403099 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-403097 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-24 | CURRENT REPORT | 0001213900-26-103215 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | CURRENT REPORT | 0001213900-26-098042 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359588 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 | 0001193125-26-359586 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006172 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006164 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001011438-26-000548 | View SEC Doc Filr Page |
| S-8 | 2026-08-14 | — | REGISTRATION STATEMENT | 0001213900-26-090164 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002174 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-349805 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | CURRENT REPORT | 0001213900-26-089137 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001473 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002912 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-24 | 4 | 0001193125-26-316458 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-24 | 4 | 0001193125-26-316457 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-295112 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006656 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276236 | View SEC Doc Filr Page |